Maggie Ming Yee Mok

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome

Kai‐Hang Yiu, Man‐Hong Jim, Chung‐Wah Siu et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 91 citations · Full text

Medicine, Endocrinology, Internal Medicine +9

Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis

D. Y. H. Yap, M. K. M., Maggie Ming Yee Mok et al. · Lara D. Veeken · 2012 · 65 citations · Full text

Medicine, Clinical Sciences, Nephrology +17

Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis

Carlos King Ho Wong, Julie Chen, Samuel Fung et al. · Nephrology Dialysis Transplantation · 2018 · 49 citations

Medicine, Nephrology, Pharmacoeconomics +17

A Longitudinal Study on the Prevalence and Risk Factors for Depression and Anxiety, Quality of Life, and Clinical Outcomes in Incident Peritoneal Dialysis Patients

Maggie Ming Yee Mok, Carmen K.M. Liu, Man Fai Lam et al. · Peritoneal Dialysis International · 2018 · 32 citations · Full text

Medicine, Nephrology, Dialysis +15